Literature DB >> 21192969

5-HT6 pharmacology inconsistencies.

Franco Borsini1, Fabio Bordi, Teresa Riccioni.   

Abstract

5-HT(6) receptors are relatively recently-discovered receptors. After an uncertain beginning, where results were ambiguous, findings are now apparently more congruent. Nevertheless, discrepancies still exist. The aim of the present manuscript is to point out some of these discrepancies, in order to reflect on the current status of the field of the 5-HT(6) receptor neuropharmacology, and where the field should move next. Examples of 5-HT(6) receptor ligand-induced changes in behavior, neurochemistry and binding highlight areas where discrepancies remain and further experimental attention is needed. Possible methodological as well as conceptual issues underlying the inconsistencies are considered in an effort to increase awareness of the need for more thorough consideration of these aspects in future research.
Copyright © 2010 Elsevier Inc. All rights reserved.

Mesh:

Substances:

Year:  2010        PMID: 21192969     DOI: 10.1016/j.pbb.2010.12.021

Source DB:  PubMed          Journal:  Pharmacol Biochem Behav        ISSN: 0091-3057            Impact factor:   3.533


  4 in total

1.  Age-Related Change in 5-HT6 Receptor Availability in Healthy Male Volunteers Measured with 11C-GSK215083 PET.

Authors:  Rajiv Radhakrishnan; Nabeel Nabulsi; Edward Gaiser; Jean-Dominique Gallezot; Shannan Henry; Beata Planeta; Shu-Fei Lin; Jim Ropchan; Wendol Williams; Evan Morris; Deepak Cyril D'Souza; Yiyun Huang; Richard E Carson; David Matuskey
Journal:  J Nucl Med       Date:  2018-04-06       Impact factor: 10.057

2.  Preclinical evaluation of [18F]2FNQ1P as the first fluorinated serotonin 5-HT6 radioligand for PET imaging.

Authors:  Guillaume Becker; Julie Colomb; Véronique Sgambato-Faure; Léon Tremblay; Thierry Billard; Luc Zimmer
Journal:  Eur J Nucl Med Mol Imaging       Date:  2014-10-21       Impact factor: 9.236

3.  5-Hydroxytryptamine receptor 6 antagonist, SB258585 exerts neuroprotection in a rat model of Streptozotocin-induced Alzheimer's disease.

Authors:  Nasrin Hashemi-Firouzi; Siamak Shahidi; Sara Soleimani-Asl; Alireza Komaki
Journal:  Metab Brain Dis       Date:  2018-04-17       Impact factor: 3.584

4.  Ro 04-6790-induced cognitive enhancement: no effect in trace conditioning and novel object recognition procedures in adult male Wistar rats.

Authors:  K E Thur; A J D Nelson; H J Cassaday
Journal:  Pharmacol Biochem Behav       Date:  2014-10-24       Impact factor: 3.533

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.